Tolvaptan in Patients With Heart Failure and Systolic Dysfunction - Tolvaptan in Patients With Heart Failure and Systolic Dysfunction

Description:

The goal of the trial was to evaluate the effect of the vasopressin V2-receptor antagonist tolvaptan compared with placebo on left ventricular end-diastolic volume (LVEDV) among patients with heart failure and reduced systolic function.